Vident Advisory
MDLN icon

Vident Advisory’s Medline Inc MDLN Stock Holding History

Vident Advisory’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$440K Buy
11,154
+18
+0.2% +$725 ﹤0.01% 1430
2026
Q1 		$496K Buy
+11,136
New +$492K ﹤0.01% 1263

Other funds holding MDLN

Carlyle Group
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $39B AUM 18.55% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Lone Pine Capital
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vident Advisory's MDLN Position: Q2 2026 in Review

Vident Advisory increased its Medline Inc (MDLN) stake by 0.16% in Q2 2026, buying an estimated $725 and bringing the position to 11,154 shares worth $440K. The position accounts for ﹤0.01% of the portfolio, ranked #1430.

Vident Advisory first reported a position in MDLN in Q1 2026 and has held it in 2 quarters since. The position peaked at $496K in Q1 2026. 409 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Vident Advisory held 11,154 shares of Medline Inc worth $440K as of Q2 2026.
  • Vident Advisory bought 18 Medline Inc shares in Q2 2026, an estimated $725.
  • Medline Inc made up ﹤0.01% of Vident Advisory's portfolio in Q2 2026, its #1430 holding.
  • Vident Advisory first reported a position in Medline Inc in Q1 2026 and has held it in 2 quarters since.
  • Vident Advisory's Medline Inc position peaked at $496K in Q1 2026.
  • 409 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.